A carregar...

Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies

Reports of fidaxomicin treatment for patients with multiple recurrent Clostridium difficile infections ([mrCDI] ie, more than 2 CDI episodes) indicate symptomatic response to this agent, but 50% have subsequent mrCDI episodes. In an effort to improve outcomes in patients with mrCDI we used novel reg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Soriano, Melinda M., Danziger, Larry H., Gerding, Dale N., Johnson, Stuart
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4281782/
https://ncbi.nlm.nih.gov/pubmed/25734139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofu069
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!